Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2001

View Archived Issues

ProstaScint scan aids in imaging early recurrent disease after prostatectomy

Tamsulosin highlighted at AUA meeting

Alexion's therapeutic agonist antibodies show promise against thrombocytopenia

Health Canada approves clinical evaluation of ISAtx-247 for three indications

Long-term benefits of Integrilin emerge from ESPRIT study

Pharmexa creates new genomics company

Berlex commences launch of Campath in U.S.

Phytotherapy compared to alpha-adrenoceptor blockade with tamsulosin in BPH

Corvas completes phase IIa PTCA trial with rNAPc2

AUA news: first use of stem cells to regenerate and restore function in sphincter muscle

The Medicines Company and Ferrer establish Angiomax collaboration

DHEA as a physiological means of treating female sexual dysfunction due to ADS

Selective inhibitors of p38 kinase useful in inflammatory conditions

Merck presents new series of indole-based tyrosine kinase inhibitors

Uroselective alpha1A/1L-adrenoceptor antagonists designed by Italian investigators

GlaxoSmithKline portfolio includes newly patented 5-HT7 antagonists

Novel TNF-alpha inhibitors and potential therapeutic uses reported by Sanofi-Synthelabo

New Celltech compounds useful for disease states associated with angiogenesis

DuPont discovers novel compounds with utility as chemokine receptor modulators

Protarga initiates multinational phase II program for Taxoprexin

Combination gene therapy with the cytokines IL-12 and IFN-alpha under study at Valentis

AltaRex enters HCA collaboration with Epigen

New data confirm broad-spectrum activity of HspE7 for treatment of HPV-related diseases

Potent and selective RXR ligand with hypoglycemic activity identified at Allergan

New CMV retinitis treatment option for AIDS patients available from Roche

Promising phase I trial results reported at AUA for MAb targeting PSMA extracellular domain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...